We are live on ! Find out more
YF

Yu Fan Portfolio holdings

AUM $97M
1-Year Est. Return 57.2%
This Fund
S&P 500
This Quarter Est. Return
+19.53%
1 Year Est. Return
+57.2%
3 Year Est. Return
-14.37%
5 Year Est. Return
-61.92%
10 Year Est. Return
AUM
$97M
AUM Growth
+$4.74M
Cap. Flow
+$9.45M
Cap. Flow %
9.74%
Top 10 Hldgs %
100%
Holding
8
New
3
Increased
Reduced
1
Closed

Top Sells

1
ALMS
Alumis Inc
ALMS
+$319K

Sector Composition

1 Healthcare 99.71%
2 Financials 0.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMTS
1
Kestra Medical Technologies
KMTS
$1.41B
$45.5M 46.89%
2,282,519
ALMS
2
Alumis Inc
ALMS
$3.47B
$17.1M 17.64%
776,845
-12,773
-2% -$319K
CBLL
3
CeriBell Inc
CBLL
$726M
$10.1M 10.38%
549,448
IVA
4
Inventiva
IVA
$1.07B
$8.32M 8.58%
1,500,000
WHWK
5
Whitehawk Therapeutics
WHWK
$192M
$7.14M 7.36%
2,070,000
CATX icon
6
Perspective Therapeutics
CATX
$336M
$4.4M 4.54%
+1,055,409
New +$4.46M
PMN icon
7
ProMIS Neurosciences
PMN
$119M
$4.19M 4.32%
+329,760
New +$4.92M
ABTC
8
American Bitcoin Corp
ABTC
$399M
$285K 0.29%
+20,538
New +$395K

Similar funds

Yu Fan's Q1 2026 Portfolio in Review

As of Q1 2026, Yu Fan held 8 positions worth $97M, up 5.1% from $92.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Yu Fan deployed $9.45M of net new capital in Q1 2026, opening 3 new positions. Its largest new stake was ProMIS Neurosciences: 329,760 shares worth $4.19M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, down from 100% a quarter earlier, followed by Financials.

On the sell side, the largest reduction was Alumis Inc, an estimated $319K trimmed.

  • Yu Fan's largest Q1 2026 buy was ProMIS Neurosciences: 329,760 shares worth $4.19M.
  • Yu Fan's biggest Q1 2026 reduction was Alumis Inc, cutting an estimated $319K.
  • Yu Fan's ten largest holdings make up 100% of its $97M portfolio in Q1 2026.
  • Yu Fan opened 3 new positions and closed 0 in Q1 2026.
  • Yu Fan's portfolio value rose 5.1% quarter-over-quarter to $97M.

Based on Yu Fan's 13F filing for Q1 2026, filed 18 May 2026.